Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT07654062
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT07654062
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07654062. Randomized; double masking; primary purpose prevention. Start 2026-07 (anticipated); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- Acronym
- DREAM-PRE
- Condition
- Prediabetes
- Condition
- Impaired Fasting Glucose
- Condition
- Impaired Glucose Tolerance (Prediabetes)
- Intervention (Drug)
- Mazdutide
- Intervention (Drug)
- Placebo
- Intervention (Behavioral)
- Standardized Lifestyle Intervention
- Lead sponsor
- Shandong Provincial Hospital
- Collaborator
- Innovent Biologics, Inc.
Record details
- Record id
cardio:ct-nct07654062- Content hash
1f030be2a9a5b05a328ed4ca3fe6bc9636ddc8938df6ec552a7dfacf731cd02e